|
Nov 14
|
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
|
|
Nov 10
|
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024
|
|
Nov 8
|
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
|
|
Oct 3
|
Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
|
|
Oct 3
|
Where Will Summit Therapeutics Be in 3 Years?
|
|
Oct 2
|
Has Summit Therapeutics Stock Already Peaked?
|
|
Sep 30
|
Is Summit Therapeutics Stock a Buy?
|
|
Sep 29
|
2 High-Potential Growth Stocks You Shouldn't Overlook
|
|
Sep 28
|
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
|
|
Sep 26
|
Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024?
|
|
Sep 25
|
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
|
|
Jul 29
|
Summit Therapeutics to Host Second Quarter 2024 Financial Results & Operational Progress Call on August 6, 2024
|
|
Jul 25
|
Summit Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Development of Ivonescimab
|
|
May 2
|
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
|
|
May 2
|
Q1 2024 Summit Therapeutics Inc Earnings Call
|
|
May 1
|
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
|
|
Apr 24
|
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
|
|
Apr 11
|
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
|
|
Apr 10
|
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
|